Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | NQO1 | P15559 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31344274 | 1.00 | MCL1 (0.47) | MCL1NQO1MEN1KMT2ANPC1 | |
| SCHEMBL4086139 | 0.88 | MEN1 (0.48) | MCL1NQO1MEN1KMT2ANPC1 | |
| SCHEMBL8728352 | 0.84 | KDM4E (0.57) | MEN1KMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL24025683 | 0.84 | MCL1 (0.47) | MCL1NQO1MEN1KMT2ANPC1 | |
| SCHEMBL12919918 | 0.84 | MCL1 (0.61) | MCL1NQO1MEN1KMT2ANPC1 | |
| SCHEMBL30696154 | 0.83 | SMN1; SMN2 (0.48) | MCL1NQO1MEN1KMT2ANPC1 | |
| SCHEMBL19134008 | 0.81 | MCL1 (0.45) | MCL1NQO1MEN1KMT2ANPC1 | |
| SCHEMBL869935 | 0.80 | KDM4E (0.67) | MCL1NQO1KDM4EALDH1A1MAPT | |
| SCHEMBL12221067 | 0.80 | CYP3A4 (0.53) | MCL1NQO1ACHEKDM4EALDH1A1 | |
| SCHEMBL13609432 | 0.80 | MEN1 (0.47) | MCL1NQO1MEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-0620500-A2 | Resist and pattern formation using the same | HITACHI, LTD. (JP) | 1994-10-19 | — | — | EP | claimed |
| JP-5000945-A | — | — | None | — | — | JP | disclosed |
| EP-4443155-B1 | ENCAPSULATED PRE-ANALYTIC WORKFLOWS FOR FLOW-THROUGH DEVICES, LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC ANALYSIS | WATERS TECHNOLOGIES CORP (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12487210-B2 | Encapsulated pre-analytic workflows for flow-through devices, liquid chromatography and mass spectrometric analysis | WATERS TECHNOLOGIES CORPORATION (US) | 2025-12-02 | — | — | US | disclosed |
| US-12194084-B2 | Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses | NORTHWESTERN UNIVERSITY (US) | 2025-01-14 | — | — | US | disclosed |
| US-12117450-B2 | DNA-cage erasable labels for fluorescence-based pathology | OHIO STATE INNOVATION FOUNDATION (US) | 2024-10-15 | — | — | US | disclosed |
| EP-4443155-A2 | ENCAPSULATED PRE-ANALYTIC WORKFLOWS FOR FLOW-THROUGH DEVICES, LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC ANALYSIS | Waters Technologies Corporation (US) | 2024-10-09 | — | — | EP | disclosed |
| EP-3491374-B1 | ENCAPSULATED PRE-ANALYTIC WORKFLOW REAGENTS FOR FLOW-THROUGH DEVICES, LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC ANALYSIS | WATERS TECHNOLOGIES CORP (US) | 2024-10-09 | — | — | EP | disclosed |
| CN-115820598-B | Haloalkane dehalogenase DhaA mutant with improved tolerance to organic solvents and application thereof | 天津大学 | 2024-07-09 | — | — | CN | disclosed |
| CN-115820598-A | Haloalkane dehalogenase DhaA mutant with improved organic solvent tolerance and application thereof | 天津大学 | 2023-03-21 | — | — | CN | disclosed |
| WO-1997026300-A1 | COMBINATORIAL PROCESS FOR PREPARING SUBSTITUTED INDANE LIBRARIES | ELI LILLY AND COMPANY (US) | 1997-07-24 | — | — | WO | disclosed |
| EP-0703218-A1 | Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists | ELI LILLY AND COMPANY (US) | 1996-03-27 | — | — | EP | disclosed |
| WO-1996005828-A1 | PYRROLIDINYL DI-CARBOXYLIC ACID DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1996-02-29 | — | — | WO | disclosed |
| EP-0620500-A2 | Resist and pattern formation using the same | HITACHI, LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |
| EP-0534316-A1 | Use of alkylated polyethylenimines to concentrate bile acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-03-31 | — | — | EP | disclosed |
| JP-H05945-A | CARCINOSTATIC AGENT | NIKKO KYODO CO LTD | 1993-01-08 | — | — | JP | disclosed |
| WO-1992012635-A1 | METHODS OF TRANSCRIPTIONALLY MODULATING GENE EXPRESSION OF VIRAL GENES AND OTHER GENES | ONCOGENE SCIENCE, INC. (US) | 1992-08-06 | — | — | WO | disclosed |
| EP-0462229-A4 | CHEMICALLY MODIFIED CD4 PEPTIDE FRAGMENTS HAVING ANTI-RETROVIRAL PROPERTIES | — | 1992-03-11 | — | — | EP | disclosed |
| EP-0462229-A1 | CHEMICALLY MODIFIED CD4 PEPTIDE FRAGMENTS HAVING ANTI-RETROVIRAL PROPERTIES | GENELABS, INCORPORATED (US) | 1991-12-27 | — | — | EP | disclosed |